1. Home
  2. PTRN vs TVTX Comparison

PTRN vs TVTX Comparison

Compare PTRN & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pattern Group Inc.

PTRN

Pattern Group Inc.

HOLD

Current Price

$20.67

Market Cap

5.0B

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$63.53

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTRN
TVTX
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.3B
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
PTRN
TVTX
Price
$20.67
$63.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
13
Target Price
$19.56
$40.62
AVG Volume (30 Days)
1.7M
1.6M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.89
EPS
0.31
N/A
Revenue
$2,501,315,000.00
N/A
Revenue This Year
$27.89
$44.76
Revenue Next Year
$22.19
$35.51
P/E Ratio
$69.16
N/A
Revenue Growth
39.26
N/A
52 Week Low
$9.19
$17.05
52 Week High
$29.80
$66.24

Technical Indicators

Market Signals
Indicator
PTRN
TVTX
Relative Strength Index (RSI) 38.21 65.04
Support Level $19.50 $53.76
Resistance Level $25.85 $66.24
Average True Range (ATR) 1.49 2.56
MACD -0.28 0.30
Stochastic Oscillator 22.05 75.27

Price Performance

Historical Comparison
PTRN
TVTX

About PTRN Pattern Group Inc.

Pattern Group Inc is an e-commerce accelerator that uses its technology platform, data science, and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics, and customer service. Brand partners that contract with the Company operate in various industries, including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors, and consumer electronics. The Company mainly derives its revenue in the United States by selling products to customers via online marketplaces. The company genrates majority of revenue from the US.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: